Comparison of morphological and functional alterations of human saphenous veins after seven and fourteen days of ex vivo perfusion

European Surgical Research

Volumn 36, Issue 5, 2004, Pages 274-281

  Paroz, A ^a   Probst, H ^a   Saucy, F ^a   Mazzolai, Lucia ^a   Rizzo, Elena ^a   Ris, H B ^a   Corpataux, J M ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Human saphenous vein; Intimal hyperplasia; Perfusion culture

Indexed keywords

ALPHA ACTIN; BLOOD CLOTTING FACTOR 8; CD34 ANTIGEN; KI 67 ANTIGEN; MESSENGER RNA;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FIBRINOLYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; PERFUSION; PRIORITY JOURNAL; SAPHENOUS VEIN; SMOOTH MUSCLE; STATISTICAL SIGNIFICANCE;

ACTINS; ANTIGENS, CD34; BLOTTING, NORTHERN; FACTOR VIII; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NITROPRUSSIDE; NOREPINEPHRINE; PERFUSION; PLASMINOGEN ACTIVATOR INHIBITOR 1; SAPHENOUS VEIN; TIME FACTORS; TUNICA INTIMA; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 4644338454     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079912     Document Type: Article

References (34)

1. Coburn MC, Carney WI Jr: Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula, discussion 3-4. J Vasc Surg 1994;20:896-902.
2. Murphy GJ, White SA, Knight AJ, Doughman T, Nicholson ML: Long-term results of arteriovenous fistulas using transposed autologous basilic vein. Br J Surg 2000;87:819-823.
3. Angelini GD, Christie MI, Bryan AJ, Lewis MJ: Surgical preparation impairs release of endothelium-derived relaxing factor from human saphenous vein. Ann Thorac Surg 1989;48:417-420.
4. Dhein S, Reiss N, Gerwin R, Borowski A, Korb H, Klaus W, et al: Endothelial function and contractility of human vena saphena magna prepared for aortocoronary bypass grafting. Thorac Cardiovasc Surg 1991;39:66-69.
5. Davies MG, Hagen PO: Pathophysiology of vein graft failure: A review. Eur J Vasc Endovasc Surg 1995;9:7-18.
6. Haudenschild C, Gould KE, Quist WC, LoGerfo FW: Protection of endothelium in vessel segments excised for grafting. Circulation 1981;64:II101-II107.
7. Lawrie GM, Weilbacher DE, Henry PD: Endothelium-dependent relaxation in human saphenous vein grafts: Effects of preparation and clinicopathologic correlations. J Thorac Cardiovasc Surg 1990;100:612-620.
8. LoGerfo FW, Quist WC, Cantelmo NL, Haudenschild CC: Integrity of vein grafts as a function of initial intimal and medial preservation. Circulation 1983;68:II117-124.
9. Soyombo AA, Angelini GD, Bryan AJ, Newby AC: Surgical preparation induces injury and promotes smooth muscle cell proliferation in a culture of human saphenous vein. Cardiovasc Res 1993;27:1961-1967.
10. Salam T, Lumsden A, Suggs W, Ku D: Low shear stress promotes intimal hyperplasia thickening. J Vasc Invest 1996;2:12-22.
11. Mavromatis K, Fukai T, Tate M, Chesler N, Ku DN, Galis ZS: Early effects of arterial hemodynamic conditions on human saphenous veins perfused ex vivo. Arterioscler Thromb Vasc Biol 2000;20:1889-2895.
12. Porter KE, Nydahl S, Dunlop P, Varty K, Thrush AJ, London NJ: The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia. Cardiovasc Res 1996;31:607-614.
13. Angelini GD, Soyombo AA, Newby AC: Winner of the ESVS prize 1990. Smooth muscle cell proliferation in response to injury in an organ culture of human saphenous vein. Eur J Vasc Surg 1991;5:5-12.
14. Kranzhofer A, Baker AH, George SJ, Newby AC: Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein. Arterioscler Thromb Vasc Biol 1999;19:255-265.
15. Masood I, Porter KE, London NJ: Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein [see comments]. Comment in: Br J Surg 1997;84:1479. Br J Surg 1997;84:499-503.
16. Varty K, Allen KE, Jones L, Sayers RD, Ratliff DA, Bell PR, et al: The influence of low molecular weight heparin on neointimal proliferation in cultured human saphenous vein. Eur J Vasc Surg 1994;8:174-178.
17. Soyombo AA, Angelini GD, Bryan AJ, Jasani B, Newby AC: Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol 1990;137:1401-1410.
18. Barner HB, Fischer VW: Endothelial preservation in human saphenous veins harvested for coronary grafting [letter] [see comments]. Comment in: J Thorac Cardiovasc Surg 1990;100:148-149. J Thorac Cardiovasc Surg 1990;100:149-150.
19. 125I-LDL in an in vitro porcine arterial organ-support system. Arterioscler Thromb 1992;12:1313-1328.
20. Bardy N, Karillon GJ, Merval R, Samuel JL, Tedgui A: Differential effects of pressure and flow on DNA and protein synthesis and on fibronectin expression by arteries in a novel organ culture system. Circ Res 1995;77:684-694.
21. Bardy N, Merval R, Benessiano J, Samuel JL, Tedgui A: Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta: Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res 1996;79:70-78.
22. Golledge J, Gosling M, Turner RJ, Standfield NJ, Powell JT: Arterial flow induces changes in saphenous vein endothelium proteins transduced by cation channels. Eur J Vasc Endovasc Surg 2000;19:545-550.
23. Holt CM, Francis SE, Newby AC, Rogers S, Gadsdon PA, Taylor T, et al: Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery. Ann Thorac Surg 1993;55:1522-1528.
24. Wilson YG, Davies AH, Southgate K, Currie IC, Sheffield E, Baird RN, et al: Vein quality influences neointimal hyperplasia in an organ culture model of human saphenous vein. Eur J Vasc Endovasc Surg 1997;13:557-562.
25. Patterson MA, Leville CD, Hower CD, Jean-Claude JM, Seabrook GR, Towne JB, et al: Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture. J Surg Res 2001;95:67-72.
26. Golledge J, Tumer RJ, Harley SL, Springall DR, Powell JT: Development of an in vitro model to study the response of saphenous vein endothelium to pulsatile arterial flow and circumferential deformation. Eur J Vasc Endovasc Surg 1997;13:605-612.
27. Michiels C, Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Janssens D, Remacle J: Perfused human saphenous veins for the study of the origin of varicose veins: Role of the endothelium and of hypoxia. Int Angiol 1997;16:134-141.
28. Surowiec SM, Conklin BS, Li JS, Lin PH, Weiss VJ, Lumsden AB, et al: A new perfusion culture system used to study human vein. J Surg Res 2000;88:34-41.
29. Labadie RF, Antaki JF, Williams JL, Katyal S, Ligush J, Watkins SC, et al: Pulsatile perfusion system for ex vivo investigation of biochemical pathways in intact vascular tissue. Am J Physiol 1996;270:H760-H768.
30. Schwartz LB, Purut CM, Massey MF, Pence JC, Smith PK, McCann RL: Effects of pulsatile perfusion on human saphenous vein vasoreactivity: A preliminary report. Cardiovasc Surg 1996;4:143-149.
31. Porter KE, Varty K, Jones L, Bell PR, London NJ: Human saphenous vein organ culture: A useful model of intimal hyperplasia? Eur J Vasc Endovasc Surg 1996;11:48-58.
32. Redmond EM, Cullen JP, Cahill PA, Sitzmann JV, Stefansson S, Lawrence DA, et al: Endothelial cells inhibit flow-induced smooth muscle cell migration: Role of plasminogen activator inhibitor-1. Circulation 2001;103:597-603.
33. Xiaoli M, Wenying H, Mingpeng S: Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation [discussion S5]. Int J Cardiol 1998;66(suppl 1):S57-S64.
34. Kauhanen P, Siren V, Carpen O, Vaheri A, Lepantalo M, Lassila R: Plasminogen activator inhibitor-1 in neointima of vein grafts: Its role in reduced fibrinolytic potential and graft failure. Circulation 1997;96:1783-1789.